Literature DB >> 10313842

Cost-benefits of measles eradication: effects of a federal intervention.

R B Albritton.   

Abstract

This study applies time-series experimentation methods in estimating costs and benefits of measles eradication efforts conducted by the Center for Disease Control beginning in 1966. Application of an integrated moving average model, explicated by Box and Tiao, in an interrupted-time-series design, facilitates estimation of reductions in measles cases attributable to federally sponsored eradication efforts and provides a basis for applying cost-benefit standards to this public policy.

Mesh:

Year:  1978        PMID: 10313842

Source DB:  PubMed          Journal:  Policy Anal        ISSN: 0098-2067


  7 in total

1.  Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.

Authors:  G M Ginsberg; T H Tulchinsky
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

2.  Social, economic and psychological impacts of childhood diseases subject to immunization.

Authors:  B Velimirovic
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

3.  Hygieia at the scales: Weighing the costs and effectiveness of prevention/promotion, with special reference to mental retardation.

Authors:  M Bloom
Journal:  J Prim Prev       Date:  1986-09

4.  Assessing prevention effectiveness using data to drive program decisions.

Authors:  S B Thacker; J P Koplan; W R Taylor; A R Hinman; M F Katz; W L Roper
Journal:  Public Health Rep       Date:  1994 Mar-Apr       Impact factor: 2.792

5.  Measles eradication policies.

Authors:  N D Noah
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-03

6.  Population-based versus practice-based recall for childhood immunizations: a randomized controlled comparative effectiveness trial.

Authors:  Allison Kempe; Alison Saville; L Miriam Dickinson; Sheri Eisert; Joni Reynolds; Diana Herrero; Brenda Beaty; Karen Albright; Eva Dibert; Vicky Koehler; Steven Lockhart; Ned Calonge
Journal:  Am J Public Health       Date:  2012-12-13       Impact factor: 9.308

7.  Benefits, risks and costs of immunization for measles, mumps and rubella.

Authors:  C C White; J P Koplan; W A Orenstein
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.